Skip to main content

MoneyWorks4Me

Ajanta Pharma informs about board meeting

19 Oct 2023 Evaluate
Ajanta Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 31/10/2023 to consider and approve Unaudited Consolidated and Standalone Financial Results for the second quarter and half year ended 30.09.2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1875.55
Dr. Reddys Labs. 1374.20
Cipla 1395.00
Lupin 1970.25
Zydus Lifesciences 1203.35
View more..